PMCB
NASDAQ
US
PharmaCyte Biotech, Inc. - Common Stock
$0.69
▲ +$0.00
(+0.10%)
Vol 73K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.3M
ROE
-2.5%
Margin
-4184.2%
D/E
0.00
Beta
0.39
52W
$1–$2
Wall Street Consensus
6 analysts · Feb 20230
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
APRE
Aprea Therapeutics Inc
$6.0M
GRDX
GridAI Technologies Corp
RNAZ
Transcode Therapeutics Inc
$6.3M
CELZ
Creative Medical Technology Holdings Inc
$5.1M
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M
TCRT
Alaunos Therapeutics Inc
$7.2M
XBIO
Xenetic Biosciences Inc
$5.0M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
Earnings
Beat rate: 0.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | $-0.09 | — |
| Sep 2025 | — | $-0.10 | — |
| Jun 2025 | — | $-0.29 | — |
| Mar 2025 | — | $0.14 | — |
Fundamentals Trend
| Metric | 2025-07-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -2.5% | 46.0% | -2.5% | -2.5% | -2.5% | -2.5% |
| P/E (TTM) | — | 0.31 | — | — | — | — |
| Net Margin | — | -4184.2% | -4184.2% | -4184.2% | -4184.2% | -4184.2% |
| Gross Margin | — | 81.7% | 81.7% | 81.7% | 81.7% | 81.7% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 18.01 | 14.20 | 18.01 | 18.01 | 18.01 | 18.01 |
Key Ratios
ROA (TTM)
-2.3%
P/S (TTM)
183.89
P/B
0.2
EPS (TTM)
$-0.15
CF/Share
$-0.21
52W High
$1.90
52W Low
$0.63
$0.63
52-Week Range
$1.90
How does PMCB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PMCB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
183.9
▲
1331%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.2
▼
93%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PMCB profitability vs Biotechnology peers
ROE
-2.5%
▲
96%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-4184.2%
▼
1359%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
81.7%
▲
4%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-2.3%
▲
95%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
PMCB financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
18.0
▲
306%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.4
▼
60%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
PMCB fundamentals radar
PMCB
Peer median
Industry
PMCB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PMCB vs peers: key metrics
Latest News
No related news yet